MPS in the Pharmaceutical Industry: Opportunities, Successes & Barriers
Organized & Chaired by Roger Kamm, Cecil and Ida Green Distinguished Professor, MIT
Date: Wednesday, November 19, 2025
Location: VOCO Hotel - Laguna Hills, California
Confirmed Speakers
Roger Kamm, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT) -- Conference Chairperson
Overview of the Summit
SelectBIO MPS in the Pharmaceutical Industry: Opportunities, Successes & Barriers
Organized & Chaired by Professor Roger Kamm, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT).
This Summit held in tandem with the SelectBIO Lab-on-a-Chip and Microfluidics World Congress 2025 brings together the most up-to-date research efforts and technology developments in the Microphysiological Systems (MPS) space emphasizing the various organ-on-chip models that have been developed for studying both physiology and disease in in vitro model systems leveraging the tools and technologies of microfluidics.
Professor Kamm has assembled a collection of thought leaders from industry and academia to present the current state of the field and illustrate its applications across various functional areas. Topics will focus on the intersection of academia and the pharmaceutical industry and provide insights into the needs of pharma in disease modeling, drug development and toxicity screens that benefit from MPS technologies developed in university research and device comanies. It will also include a panel discussion on how to reach the full potential of MPS in the face of changing government priorities and the new FDA guidance.
This conference track -- in concert with the Lab-on-a-Chip and Microfluidics focus of this event -- describes an important and emerging application of microfluidics with strong emphasis by the pharmaceutical industry.
**Registered delegates receive full access to all conference tracks -- the full conference from November 17-19, 2025 for maximal scientific exchange and networking plus the co-located exhibit hall for networking with companies in this expanding space**
Abstract Submission for Oral Presentations and Posters
You can present your research in an oral presentation or via a poster while attending the meeting. Submit an abstract for consideration under the Submission tab of this conference website.
Oral Presentation Abstract Submission Deadline: August 31, 2025
Poster Abstract Submission Deadline: October 31, 2025
Agenda Topics, Themes Covered at this Summit
The unique challenges pharma faces in using MPS in their assay work stream including higher throughput, replicability and validation
How can device manufacturers best meet the needs of pharma?
How do various companies currently use MPS and for what applications?
How much does cost influence the decision of pharma to adopt a new technology?
How will the new FDA announcement “to phase out the animal testing requirement for monoclonal antibodies and other drugs” affect your use of MPS?
Best practices in pharmaceutical applications
Model qualification for assessing biologics and other delivery modalities
Integrating PBPK computational methods with MPS
What are the new questions of interest for pharma?
What are some of the success stories of complex in vitro systems in your company?
